Autoantibodies to the platelet-derived growth factor receptor in systemic sclerosis
Journal Title: Reumatologia - Year 2006, Vol 44, Issue 5
Abstract
This article briefly reviews the structure and function of platelet-derived growth factor and its receptor. The authors describe presence of autoantibodies against platelet-derived growth factor receptor in systemic sclerosis, and emphasize their probable influence on pathogenesis of the disease
Authors and Affiliations
Mariusz Puszczewicz, Grażyna Białkowska-Puszczewicz
Keywords
Related Articles
- EP ID EP159891
- DOI -
- Views 72
- Downloads 0
Zespół SAPHO – odmienność przebiegu – trudności diagnostyczne
Zespół SAPHO jest chorobą heterogenną ze współistnieniem zmian kostno-stawowych o wielomiejscowej lokalizacji, zmian skórnych i narządowych. Do najczęstszych objawów kostno-stawowych należą: bóle przedniej ściany klatk...
Usefulness of anti-cyclic citrullinated peptide autoantibodies assays in differential diagnosis of polyarthritis
An early stage of rheumatoid arthritis (RA) has frequently an atypical course and it is difficult to differentiate it from other types of polyarthritis. It has been proved, that anti-cyclic citrullinated peptide antibodi...
Low oxygen tension promotes redifferentiation of dedifferentiated human articular chondrocytes in vitro
Articular cartilage degradation is a main cause of joint destruction in rheumatic diseases. An attractive possibility for cartilage repair is the use of cultured in vitro chondrocytes. However, cultured chondrocytes unde...
Coexistence of Wegener's granulomatosis and systemic lupus erythmatosus - presentation of case with diagnosis for discussion
Systemic vasculitides are a heterogenic group of diseases characterized by inflammation and necrosis of blood vessels or perivascular region. Vasculitides may occur as a main symptom of many different underlying diseas...
The value of the assessment of interleukin-6 (IL-6), matrix metalloproteinases and their inhibitors in serum in the assessment of rheumatoid arthritis activity
The aim of the study was to explore whether the serum level of interleukin 6 (IL-6) is correlated with matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), and with clinical markers of th...